Factors predictive for response of follicular and mantle-cell lymphoma to rituximab

被引：0
|
作者：
Michael Pfreundschuh
机构：
[1] Professor of Internal Medicine at Saarland University Medical School,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：184 / 185
页数：1
相关论文
共 50 条
  • [1] Factors predictive for response of follicular and mantle-cell lymphoma to rituximab
    Pfreundschuh, M
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (04): : 184 - 185
  • [2] The effect of Rituximab on patients with follicular and mantle-cell lymphoma
    Ghielmini, M
    Schmitz, SFH
    Bürki, K
    Pichert, G
    Betticher, DC
    Stupp, R
    Wernli, M
    Lohri, A
    Schmitter, D
    Bertoni, F
    Cerny, T
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 123 - 126
  • [3] Maintenance rituximab in mantle-cell lymphoma
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2017, 18 (11): : E647 - E647
  • [4] Lenalidomide plus Rituximab for Mantle-Cell Lymphoma
    Tsuda, Kenji
    Tanimoto, Tetsuya
    Komatsu, Tsunehiko
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (08): : 792 - 793
  • [5] Is rituximab effective as a single agent in mantle-cell lymphoma?
    Antonio J Grillo-López
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 500 - 501
  • [6] Is rituximab effective as a single agent in mantle-cell lymphoma?
    Grillo-López, AJ
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (10): : 500 - 501
  • [7] Lenalidomide plus Rituximab for Mantle-Cell Lymphoma REPLY
    Ruan, Jia
    Leonard, John P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (08): : 793 - 793
  • [8] Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
    Ruan, Jia
    Martin, Peter
    Shah, Bijal
    Schuster, Stephen J.
    Smith, Sonali M.
    Furman, Richard R.
    Christos, Paul
    Rodriguez, Amelyn
    Svoboda, Jakub
    Lewis, Jessica
    Katz, Orel
    Coleman, Morton
    Leonard, John P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19): : 1835 - 1844
  • [9] Mantle-Cell Lymphoma
    Yavorkovsky, Leonid L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1049 - 1050
  • [10] Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
    Wang, Michael L.
    Jurczak, Wojciech
    Jerkeman, Mats
    Trotman, Judith
    Zinzani, Pier L.
    Belada, David
    Boccomini, Carola
    Flinn, Ian W.
    Giri, Pratyush
    Goy, Andre
    Hamlin, Paul A.
    Hermine, Olivier
    Hernandez-Rivas, Jose-Angel
    Hong, Xiaonan
    Kim, Seok Jin
    Lewis, David
    Mishima, Yuko
    Ozcan, Muhit
    Perini, Guilherme F.
    Pocock, Christopher
    Song, Yuqin
    Spurgeon, Stephen E.
    Storring, John M.
    Walewski, Jan
    Zhu, Jun
    Qin, Rui
    Henninger, Todd
    Deshpande, Sanjay
    Howes, Angela
    Le Gouill, Steven
    Dreyling, Martin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2482 - 2494
12345